• Corpus ID: 78115992

Drugs Acting on Blood Coagulation system and theirMechanism of Action: A review

  title={Drugs Acting on Blood Coagulation system and theirMechanism of Action: A review},
  author={B. Srividya},
  journal={Research and Reviews: Journal of Pharmacology and Toxicological Studies},
  • B. Srividya
  • Published 2016
  • Medicine, Biology
  • Research and Reviews: Journal of Pharmacology and Toxicological Studies
This review mainly explains about the different classes of the drugs which affects the blood coagulation and mechanism of action of the drugs on the coagulation of the blood system. The mechanism of blood coagulation is explained. The impact of different drugs on the blood coagulation system, their way of action on blood clots, the inhibition action on the receptors is clearly discussed. 



Plasma Fibrinogen Concentrations in Patients with Solid Tumors and Therapeutic Improvements by Combining Anticoagulants or FibrinolyticalAgents

The relationship between plasma/solid tumor fibrinogen levels and mechanisms of action by anticoagulants and fibrinolytic agents is discussed.

A Review on Antiplatelet Drugs and Anticoagulants

Antiplatelet Drugs and Anticoagulants drugs help prevent dangerous blood clots from forming. These are used to control the risk heart attack or stroke, in these cases they want to use by doctors

Virtual Screening for the Discovery of New Anticoagulants

Recent results obtained by the speaker demonstrate the discovery using Virtual Screening (VS) of a novel molecular scaffold, different to the previous ones based on heparin, using this alternate approach to identify some at least weakly-binding molecules for further refinement.

P-Selectin is a Key Molecule Underlying the Pathophysiology of Aspirin- Exacerbated Respiratory Disease

This work aimed to clarify platelet activation and key molecules on platelets, which are mainly associated with the mechanism underlying aspirin-exacerbated respiratory disease.

Role of Novel Oral Anticoagulants in Primary and Secondary Thromboprophylaxis in Cancer

Although the routine use of novel oral anticoagulants for the prevention or treatment of venous thromboembolism in cancer patients cannot be recommended at this time, the development of Phase III trials assessing their efficacy and safety in patients with active malignancies compared to the current standard of care treatment with low molecular weight heparin is strongly supported.

Aspirin Inhibition of ñ-Granules Release is Associated with Sirt1/AMPKand PI3K/Akt Pathway in Thrombin-Activated Platelets

The results provide new evidence that the aspirin inhibiting platelet α-granules release not only is associated with suppressing Akt activation but also linked to activating Sirt1/AMPK pathway in thrombin-activated platelets.

Screening and Identification of Salicin Compound from Desmodium gangeticum and its In vivo Anticancer Activity and Docking Studies with Cyclooxygenase (COX) Proteins from Mus musculus

The extraction, isolation and identification of salicin and its interaction with COX-1 andCOX-2 derivatives, which may be useful for drug-designing for anti-cancer activities are reported.

Possible Role of the Transglutaminase-Catalyzed Reactions in the Pathogenesis of Neurodegenerative Diseases

The possible molecular mechanisms responsible for neurodegenerative diseases and the possible therapeutic effects of transglutaminase inhibitors for patients with diseases characterized by aberrant transglUTaminase activity are focused on.

The Level of Natural Anticoagulants in Transfusion Dependent Thalassemia Patients in Kelantan, Northeastern Malaysia

There was a significantly decreased Protein C and free protein S in thalassemia patients which might suggests hypercoagulable state in thAlas, it is believed that many more study to look for other parameters contributing to hyper coagulate state inThalassemi patients is needed.

Hypothetical Mechanism of Aspirin-Exacerbated Respiratory Disease Based on Recent Investigations of Gene Polymorphisms in Japanese Patients

A schematically sketching the course of NSAIDs-triggered hypersensitivity with genes, such as asthma-associated genes, that may initiate susceptibility to AERD, and that may accelerate pathogenesis and induce onset of A ERD is presented.